Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: The main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-α. Results of the CML89 trial of the Spanish collaborative group on interferon-α2a and CML

1. Steegmann, J.L.
2. Odriozola, J.
3. Rodriguez-Salvanés, F.
4. Giraldo, P.
5. García-Laraña, J.
6. Ferro, M.T.
7. Benítez, E.
8. Pérez-Pons, C.
9. Giralt, M.
10. Escribano, L.
11. Lavilla, E.
12. Miguel, A.
13. Areal, C.
14. Pérez-Encinas, M.
15. Abad, A.
16. Maldonado, J.
17. Massagué, I.
18. Fernández-Rañada, J.M.